يعرض 1 - 20 نتائج من 104 نتيجة بحث عن '"DUREAU-POURNIN, C."', وقت الاستعلام: 0.59s تنقيح النتائج
  1. 1
    Academic Journal
    Cardiovascular or renal disease (CVRD) complication and mortality incidence for type 2 diabetics with a single or without CVRD comorbidity: A 5-year SNDS nationwide claims database cohort study

    المؤلفون: Jourdain, P., Blin, P., Zaoui, P., Guiard, E., Sakr, D., Bernard, M.-A., Dureau-Pournin, C., Lassalle, R., Thomas-Delecourt, F., Bineau, S., Moore, N., Droz-Perroteau, C., Joubert, M.

    المصدر: Archives of Cardiovascular Diseases Supplements ; volume 15, issue 1, page 110 ; ISSN 1878-6480

    الاتاحة: http://dx.doi.org/10.1016/j.acvdsp.2022.10.212
    https://api.elsevier.com/content/article/PII:S1878648022004931?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S1878648022004931?httpAccept=text/plain

    View record in BASE

    أضف إلى المفضلة
  2. 2
    Academic Journal
    Should dual antiplatelet therapy be maintained beyond one year after a myocardial infarction? A cohort study within the French SNDS nationwide claims database

    المؤلفون: Blin, P, Danchin, N, Benichou, J, Dureau-Pournin, C, Guiard, E, Sakr, D, Jove, J, Lassalle, R, Droz-Perroteau, C, Moore, N

    المصدر: European Heart Journal ; volume 43, issue Supplement_2 ; ISSN 0195-668X 1522-9645

    الاتاحة: https://doi.org/10.1093/eurheartj/ehac544.1313
    https://academic.oup.com/eurheartj/article-pdf/43/Supplement_2/ehac544.1313/46364850/ehac544.1313.pdf

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Academic Journal
    EE600 Cumulative Cardiovascular or Renal Disease (CVRD) Hospital Costs for Type 2 Diabetics Free of CVRD at Baseline: A 5-Year Cohort Study in the SNDS Nationwide Claims Database

    المؤلفون: Blin, P, Zaoui, P, Joubert, M, Guiard, E, Sakr, D, Dureau-Pournin, C, Bernard, MA, Lassalle, R, Thomas-Delecourt, F, Bineau, S, Moore, N, Droz-Perroteau, C, Jourdain, P

    المصدر: Value in Health ; volume 25, issue 12, page S173 ; ISSN 1098-3015

    الاتاحة: http://dx.doi.org/10.1016/j.jval.2022.09.839
    https://api.elsevier.com/content/article/PII:S1098301522030431?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S1098301522030431?httpAccept=text/plain

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Academic Journal
    Surveillance active de la sécurité des vaccins contre la COVID-19 en vie réelle en France via les événements rapportés par les personnes vaccinées

    المؤلفون: Dureau-Pournin, C., Bernard, M-A., Lamarque, S., Lassalle, R., Droz-Perroteau, C., Guiard, E.

    المصدر: Journal of Epidemiology and Population Health ; volume 72, page 202312 ; ISSN 2950-4333

    الاتاحة: http://dx.doi.org/10.1016/j.jeph.2024.202312
    https://api.elsevier.com/content/article/PII:S2950433324001228?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S2950433324001228?httpAccept=text/plain

    View record in BASE

    أضف إلى المفضلة
  5. 5
    Academic Journal
    Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Compared to Rivaroxaban in Nonvalvular Atrial Fibrillation: Long-Term Results from a Cohort Study in the French Nationwide Claims Database ; J Am Coll Cardiol

    المؤلفون: MOORE, Nicholas, BLIN, P., COTTIN, Y., DUREAU-POURNIN, C., ABOUELFATH, A., LASSALLE, R., GUIARD, E., BALESTRA, A., MISMETTI, P., DE POUVOURVILLE, G., BENICHOU, Jacques, DROZ-PERROTEAU, C.

    مصطلحات موضوعية: PharmacoEpi-Drugs, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: 7351097; https://oskar-bordeaux.fr/handle/20.500.12278/26155

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/26155
    https://hdl.handle.net/20.500.12278/26155
    https://doi.org/10.1016/S0735-1097(20)30984-0

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Academic Journal
    Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study ; Europace

    المؤلفون: FAUCHIER, L., BLIN, P., SACHER, F., DUREAU-POURNIN, C., BERNARD, M. A., LASSALLE, R., DROZ-PERROTEAU, C., DALLONGEVILLE, J., MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: 1532-2092 (Electronic) 1099-5129 (Linking); https://oskar-bordeaux.fr/handle/20.500.12278/25977

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/25977
    https://hdl.handle.net/20.500.12278/25977
    https://doi.org/10.1093/europace/euz285

    View record in BASE

    أضف إلى المفضلة
  7. 7
    Academic Journal
    Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS ; Am J Cardiovasc Drugs

    المؤلفون: BLIN, P., DUREAU-POURNIN, C., BENICHOU, Jacques, COTTIN, Y., MISMETTI, P., ABOUELFATH, A., LASSALLE, R., DROZ, C., MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: https://oskar-bordeaux.fr/handle/20.500.12278/25806

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/25806
    https://hdl.handle.net/20.500.12278/25806
    https://doi.org/10.1007/s40256-019-00359-z

    View record in BASE

    أضف إلى المفضلة
  8. 8
    Academic Journal
    Prevalence of type 2 diabetes with stable coronary artery disease but without prior myocardial infarction or stroke and THEMIS-like patients from the SNDS French nationwide claims database

    المؤلفون: Blin, P, Darmon, P, Henry, P, Dureau-Pournin, C, Bernard, M.-A, Guiard, E, Maizi, H, Thomas-Delecourt, F, Lassalle, R, Droz-Perroteau, C, Moore, N

    المصدر: European Heart Journal ; volume 41, issue Supplement_2 ; ISSN 0195-668X 1522-9645

    مصطلحات موضوعية: Cardiology and Cardiovascular Medicine

    الاتاحة: http://dx.doi.org/10.1093/ehjci/ehaa946.1348
    http://academic.oup.com/eurheartj/article-pdf/41/Supplement_2/ehaa946.1348/34518052/ehaa946.1348.pdf

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Academic Journal
    Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation

    المؤلفون: Blin, P., Fauchier, L., Dureau-Pournin, C., Sacher, Frédéric, Dallongeville, J., Bernard, M. A., Lassalle, Regis, Droz-Perroteau, C., Moore, Nicholas

    المساهمون: CIC Bordeaux, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Université de Tours (UT), Centre de recherche Cardio-Thoracique de Bordeaux Bordeaux (CRCTB), Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidémiologie des maladies chroniques : impact des interactions gène environnement sur la santé des populations, Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, Droit et Santé, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), This study was funded by Bayer Healthcare.

    المصدر: ISSN: 0039-2499.

    مصطلحات موضوعية: atrial fibrillation, France, humans, pharmacoepidemiology, rivaroxaban, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

    Relation: info:eu-repo/semantics/altIdentifier/pmid/31390972; hal-03209508; https://hal.science/hal-03209508; https://hal.science/hal-03209508/document; https://hal.science/hal-03209508/file/BPH_Stroke_2019_Blin.pdf; PUBMED: 31390972; PUBMEDCENTRAL: PMC6727926

    الاتاحة: https://hal.science/hal-03209508
    https://hal.science/hal-03209508/document
    https://hal.science/hal-03209508/file/BPH_Stroke_2019_Blin.pdf
    https://doi.org/10.1161/strokeaha.119.025824

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Academic Journal
    Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI

    المؤلفون: DROZ-PERROTEAU, C., BLIN, P., DUREAU-POURNIN, C., THOMAS, D., DANCHIN, N., TRICOIRE, J., PAILLARD, F., HERCBERG, S., GUIZE, L., GUIARD, E., MAIZI, H., BERNARD, M. A., BENICHOU, Jacques, MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: 1958-5578 (Electronic) 0040-5957 (Linking); https://oskar-bordeaux.fr/handle/20.500.12278/7790

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/7790
    https://hdl.handle.net/20.500.12278/7790
    https://doi.org/10.1016/j.therap.2019.02.001

    View record in BASE

    أضف إلى المفضلة
  11. 11
    Academic Journal
    Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation ; Br J Clin Pharmacol

    المؤلفون: BLIN, P., DUREAU-POURNIN, C., COTTIN, Y., BENICHOU, Jacques, MISMETTI, P., ABOUELFATH, A., LASSALLE, Regis, DROZ, C., MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: 1365-2125 (Electronic) 0306-5251 (Linking); https://oskar-bordeaux.fr/handle/20.500.12278/7635

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/7635
    https://hdl.handle.net/20.500.12278/7635
    https://doi.org/10.1111/bcp.13815

    View record in BASE

    أضف إلى المفضلة
  12. 12
    Academic Journal
    Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database ; Atherosclerosis

    المؤلفون: BLIN, P., DUREAU-POURNIN, C., BENICHOU, Jacques, BONELLO, L., DALLONGEVILLE, J., DANCHIN, N., FALISSARD, B., THOMAS-DELECOURT, F., JOVE, J., LASSALLE, Regis, DROZ, C., MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: 1879-1484 (Electronic) 0021-9150 (Linking); https://oskar-bordeaux.fr/handle/20.500.12278/7634

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/7634
    https://hdl.handle.net/20.500.12278/7634
    https://doi.org/10.1016/j.atherosclerosis.2018.11.037

    View record in BASE

    أضف إلى المفضلة
  13. 13
    Academic Journal
    Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation ; Clin Pharmacol Ther

    المؤلفون: BLIN, P., DUREAU-POURNIN, C., COTTIN, Y., BENICHOU, Jacques, MISMETTI, P., ABOUELFATH, A., LASSALLE, Regis, DROZ, C., MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: 1532-6535 (Electronic) 0009-9236 (Linking); https://oskar-bordeaux.fr/handle/20.500.12278/7636

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/7636
    https://hdl.handle.net/20.500.12278/7636
    https://doi.org/10.1002/cpt.1318

    View record in BASE

    أضف إلى المفضلة
  14. 14
    Academic Journal
    Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France ; : Therapie

    المؤلفون: BENARD-LARIBIERE, Anne, Noize, Pernelle, GIRODET, P. O., Lassalle, R., Dureau-Pournin, C., Droz-Perroteau, C., Fourrier-Reglat, Annie, SALVO, Francesco, Bezin, Julien, Pariente, Antoine

    المساهمون: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)

    المصدر: ISSN: 0040-5957.

    مصطلحات موضوعية: PharmacoEpi-Drugs, CIC1401, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

    Relation: hal-03210775; https://hal.archives-ouvertes.fr/hal-03210775; https://hal.archives-ouvertes.fr/hal-03210775/document; https://hal.archives-ouvertes.fr/hal-03210775/file/S0040595718302646.pdf; PII: S0040-5957(18)30264-6

    الاتاحة: https://hal.archives-ouvertes.fr/hal-03210775
    https://hal.archives-ouvertes.fr/hal-03210775/document
    https://hal.archives-ouvertes.fr/hal-03210775/file/S0040595718302646.pdf
    https://doi.org/10.1016/j.therap.2018.12.007

    View record in BASE

    أضف إلى المفضلة
  15. 15
    Academic Journal
    Effectiveness and safety of standard and reduced dosages of dabigatran versus rivaroxaban in non-valvular atrial fibrillation: A cohort study in the SNDS French nationwide claims database

    المؤلفون: Blin, P., Cottin, Y., Dureau-Pournin, C., Abouelfath, A., Lassalle, R., Bénichou, J., De Pouvourville, G., Mismetti, P., Droz-Perroteau, C., Moore, N.

    المصدر: Archives of Cardiovascular Diseases Supplements ; volume 11, issue 1, page 120-121 ; ISSN 1878-6480

    الاتاحة: http://dx.doi.org/10.1016/j.acvdsp.2018.10.266
    https://api.elsevier.com/content/article/PII:S1878648018305214?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S1878648018305214?httpAccept=text/plain

    View record in BASE

    أضف إلى المفضلة
  16. 16
    Academic Journal
    Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting ; Clin Pharmacol Ther

    المؤلفون: BEZIN, Julien, KLUNGEL, O. H., LASSALLE, R., DUREAU-POURNIN, C., MOORE, Nicholas, PARIENTE, Antoine

    مصطلحات موضوعية: PharmacoEpi-Drugs, CIC1401, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: 1532-6535 (Electronic) 0009-9236 (Linking); https://oskar-bordeaux.fr/handle/20.500.12278/11454

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/11454
    https://hdl.handle.net/20.500.12278/11454
    https://doi.org/10.1002/cpt.864

    View record in BASE

    أضف إلى المفضلة
  17. 17
    Academic Journal
    Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database ; European Heart Journal

    المؤلفون: COTTIN, Y., BLIN, P., BENICHOU, Jacques, DUREAU-POURNIN, C., ABOUELFATH, A., LASSALLE, R., DROZ-PERROTEAU, C., MISMETTI, P., MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, CIC1401, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: https://oskar-bordeaux.fr/handle/20.500.12278/11575

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/11575
    https://hdl.handle.net/20.500.12278/11575

    View record in BASE Full Text Finder

    أضف إلى المفضلة
  18. 18
    Academic Journal
    Effectiveness and safety of standard and reduced doses of dabigatran versus rivaroxaban in non-valvular atrial fibrillation: A cohort study in the snds french nationwide claims database ; Value in Health

    المؤلفون: BLIN, P., COTTIN, Y., DUREAU-POURNIN, C., ABOUELFATH, A., LASSALLE, R., BENICHOU, Jacques, DE POUVOURVILLE, G., MISMETTI, P., DROZ-PERROTEAU, C., MOORE, Nicholas

    مصطلحات موضوعية: PharmacoEpi-Drugs, CIC1401, Sciences du Vivant [q-bio]/Santé publique et épidémiologie

    Relation: https://oskar-bordeaux.fr/handle/20.500.12278/11469

    الاتاحة: https://oskar-bordeaux.fr/handle/20.500.12278/11469
    https://hdl.handle.net/20.500.12278/11469
    https://doi.org/10.1016/j.jval.2018.09.043

    View record in BASE Full Text Finder

    أضف إلى المفضلة
  19. 19
    Academic Journal
    P4820Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database

    المؤلفون: Moore, N, Fauchier, L, Sacher, F, Dureau-Pournin, C, Bernard, M A, Lassalle, R, Dallongeville, J, Droz-Perroteau, C, Blin, P

    المصدر: European Heart Journal ; volume 39, issue suppl_1 ; ISSN 0195-668X 1522-9645

    الاتاحة: https://doi.org/10.1093/eurheartj/ehy563.p4820
    http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy563.P4820/25577245/ehy563.p4820.pdf

    View record in BASE

    أضف إلى المفضلة
  20. 20
    Academic Journal
    P3851Benefit-risk profile of dabigatran compared with vitamin-K antagonists in elderly patients with non-valvular atrial fibrillation: results from a cohort study in the French nationwide claims database

    المؤلفون: Cottin, Y, Blin, P, Benichou, J, Dureau-Pournin, C, Abouelfath, A, Lassalle, R, Droz-Perroteau, C, Mismetti, P, Moore, N

    المصدر: European Heart Journal ; volume 39, issue suppl_1 ; ISSN 0195-668X 1522-9645

    الاتاحة: https://doi.org/10.1093/eurheartj/ehy563.p3851
    http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy563.P3851/25574777/ehy563.p3851.pdf

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء